Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Stryker Q1 Profit Slips; Revenues Drop 2%; Cuts FY09 View - Update

Mon. April 20, 2009; Posted: 06:29 PM
Stocks RSS
(RTTNews) - Orthopaedic Implants and MedSurg Equipment maker Stryker Corp. (SYK | Quote | Chart | News | PowerRating), Monday reported a slight decline in first quarter profit, impacted by the global economic slowdown as well as a 2% drop in sales due to a strong dollar. Earnings per share, however, increased from last year and came in line with analysts' consensus estimate. Stryker lowered its outlook for fiscal year 2009, citing continued weaker demand for certain MedSurg Equipment products as well as consideration of slowing elective procedures for certain Orthopaedic Implant products.

Stephen MacMillan, President and Chief Executive Officer, Stryker said, "The unprecedented global economic slowdown clearly impacted our business, yet our diverse set of businesses still delivered underlying sales growth in this very challenging period as six of our eight key product franchises delivered mid-single to low double-digit constant currency revenue growth."

The Kalamazoo, Michigan-based company's net earnings for first quarter dropped 3.2% to $281.1 million from $290.5 million in the prior-year quarter. On a per-share basis, earnings for the quarter, however, increased 1.4% to $0.71 per share from last year's $0.70 per share, in line with Street estimates.

Seventeen analysts polled by Thomson Reuters expected the company to earn $0.71 per share. Analysts' estimates typically exclude special items.

In the preceding fourth quarter, Stryker recorded a 0.6% growth in net earnings to $278 million or $0.69 per share, on a 3.6% increase in net sales, helped by Orthopaedic Implants and MedSurg Equipment sales.

Net sales for the quarter declined 2.0% to $1.60 billion from $1.63 billion in the year-ago quarter, shy of analysts' consensus estimate of $1.63 billion for the quarter. On a constant currency basis, net sales increased 3.3% from last year.

Segment wise, worldwide sales of Orthopaedic Implants for the quarter were $973 million, an increase of 0.2% from the same quarter last year. MedSurg Equipment had worldwide sales of $628 million, down 5.3% from last year. On a constant currency basis, sales of Orthopaedic Implants increased 6.2% year-over-year, while sales of MedSurg Equipment decreased 1.0% from the previous year. Domestic sales for Stryker rose 0.9%, while International sales declined 7.0% from the prior-year quarter.

Operating income for the quarter dropped a modest 1.2% to $379.2 million from $383.7 million in the same quarter last year.

Gross profit as a percentage of sales for the quarter was 67.8%, compared with 69.4% last year.

In April 2009, the U.S. Internal Revenue Service issued two notices of proposed tax adjustments to the company's previously filed 2003, 2004 and 2005 income tax returns related to income tax positions taken for its cost sharing arrangements with two wholly owned entities operating in Ireland. Stryker believes it followed the applicable tax law and Treasury regulations and said it would vigorously defend these income tax positions.

For 2009, Stryker now expects earnings within a range of $2.90 - $3.10 per share, down from the earlier issued forecast of $3.12 - $3.22 per share, an increase of 2% - 10% over adjusted net earnings per share of $2.83 in fiscal year 2008.

On average, 17 analysts polled by Thomson Reuters currently expect the company to report earnings of $3.07 per share for the full-year. Analysts' estimates typically exclude one-time items.

The company now anticipates net sales to increase between 2% and 5% on a constant currency rate, however, the company anticipates an unfavorable impact on net sales of about 3.5% to 4.5% for the full year of 2009 and approximately 5.5% to 6.0% in the second quarter of 2009, if foreign currency exchange rates hold near current levels.

The company had earlier anticipated a constant currency net sales increase in the range of 6% to 9% and recording an unfavorable impact on net sales of approximately 4.5% to 5.5% in the first quarter of 2009 and an unfavorable impact on net sales of approximately 3.5% to 4.5% for the full year of 2009, if foreign currency exchange rates hold near current levels.

Amongst others in the sector, Warsaw, Indiana-based Zimmer Holdings Inc. (ZMH | Quote | Chart | News | PowerRating), is scheduled to announce its quarterly earnings results on Thursday, April 23, 2009. Sixteen analysts polled by Thomson Reuters Analysts' currently estimate Zimmer to report earnings of $0.94 for the quarter.

SYK closed Monday's regular trading at $37.42, down $0.52 or 1.37% on a volume of 4.0 million shares on the NYSE. In the past 52 weeks, the stock trended in a broad range of $30.82 - $69.00, with a three-month average of 3.40 million shares.

For comments and feedback: contact editorial@rttnews.com Copyright(c) 2009 RTTNews.com, Inc. All Rights Reserved

For full details on Stryker Corp (SYK) click here. Stryker Corp (SYK) has Short Term PowerRatings of 5. Details on Stryker Corp (SYK) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [SYK]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.